USPTO serial 79292400
O ONKO-INNATE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 18, 2022
- Examiner
- LINDEMYER, ANKHI MUKHERJEA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with O ONKO-INNATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew S. Ehard
Andrew S. Ehard Merchant & Gould P.C.P.O. Box 2910dockmpls@merchantgould.comMinneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical drugs for the treatment of cancer and immune cell related disorders; pharmaceutical preparations for the treatment of cancer and immune cell related disorders; stem cells for medical purposes; living cells for medical use; pharmaceutical and biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer and immune cell related disorders; chemicals for pharmaceutical use for the treatment of cancer and immune cell related disorders | ACTIVE | — |
| 042 | Scientific research; pharmaceutical research, development and testing services; scientific research, namely, preparation of scientific reports; advisory services relating to immunological product development and testing; scientific research, design, analysis and testing of pharmaceutical products; conducting scientific and medical research and clinical trials; scientific research in the field of immunology and cancer treatment; scientific research and testing in the field of natural killer cells; provision of scientific information in the field of immunology, cancer treatment and the treatment of immune cell related disorders; scientific and technical analysis, namely, scientific research, analysis and testing in the field of immunology, cancer treatment and the treatment of immune cell related disorders; scientific research consultancy in the field of immunology, cancer treatment and the treatment of immune cell related disorders; scientific research in the field of pharmacy; medical research; research and development of products; research relating to pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by oNKo-innate Pty Ltd
- Other trademarks owned by oNKo-innate Pty Ltd
- Other trademarks owned by oNKo-innate Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named O ONKO-INNATE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 18, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 14, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 28, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 27, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 18, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 18, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 3, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 3, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 20, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Mar 1, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Feb 13, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 20, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 3, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 3, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 14, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 13, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |